ArticleBMC gastroenterology2025
Prevalence and risk factors of metabolic dysfunction-associated fatty liver disease in the adult Georgian population: a nationwide multiregional clinic-based study.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND &
aimIn Georgia, the prevalence of MAFLD remains poorly defined, as evidence largely stems from small-scale hospital studies. This research used a nationwide multiregional clinic-based sample to estimate MAFLD prevalence and its associated factors.
methodsA cross-sectional, clinic-based study was conducted on 11,269 adults attending check-up clinics across Georgia from 2021 to 2025. A stratified random sampling approach considering age, sex, BMI, comorbidities and region was used to derive a representative analytic sample (n = 5,602). MAFLD was diagnosed using ultrasound and international consensus positive diagnostic criteria.
resultsMAFLD affected 51.6% of Georgian adults, with higher prevalence in older age, men and individuals with obesity or metabolic comorbidities. Prevalence varied significantly across regions, with the highest in Tbilisi.
conclusionMAFLD is highly prevalent in Georgia. Due to the clinic-based nature of the sample, results should be interpreted with consideration of potential selection bias.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.